Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mesut Remzi

Showing results (131-140 of 170) with videos related to

Pageof 17
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinomaEiji Kikuchi, Vitaly Margulis, Pierre I Karakiewicz, et al.
BJU International|November 8, 2008
Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node densityChristian Bolenz, Shahrokh F Shariat, Mario I Fernández, et al.
BJU International|November 17, 2009
Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomyShahrokh F Shariat, Guilherme Godoy, Yair Lotan, et al.
World Journal of Urology|September 25, 2013
Association of diabetes mellitus and metformin use with biochemical recurrence in patients treated with radical prostatectomy for prostate cancerMalte Rieken, Luis A Kluth, Evanguelos Xylinas, et al.
Urology|October 11, 2008
Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter studyMario I Fernández, Shahrokh F Shariat, Vitaly Margulis, et al.
BJU International|May 15, 2014
The role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma following radical nephroureterectomy: a retrospective studyIlaria Lucca, Wassim Kassouf, Anil Kapoor, et al.
Urologic Oncology|September 24, 2013
Does increasing the nodal yield improve outcomes in contemporary patients without nodal metastasis undergoing radical prostatectomy?Luis A Kluth, Evanguelos Xylinas, Malte Rieken, et al.
Urology|May 25, 2016
Altered Expression of the Transcription Factor Forkhead Box A1 (FOXA1) Is Associated With Poor Prognosis in Urothelial Carcinoma of the Upper Urinary TractJay D Raman, Joshua I Warrick, Carla Caruso, et al.
European Urology|October 7, 2011
The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomyThomas F Chromecki, Eugene K Cha, Harun Fajkovic, et al.
Urologic Oncology|May 11, 2010
Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomyJeffery C Wheat, Alon Z Weizer, J Stuart Wolf, et al.
Pageof 17

Showing results (131-140 of 170) with videos related to

Sort By:
Pageof 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinomaEiji Kikuchi, Vitaly Margulis, Pierre I Karakiewicz, et al.
BJU International|November 8, 2008
Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node densityChristian Bolenz, Shahrokh F Shariat, Mario I Fernández, et al.
BJU International|November 17, 2009
Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomyShahrokh F Shariat, Guilherme Godoy, Yair Lotan, et al.
World Journal of Urology|September 25, 2013
Association of diabetes mellitus and metformin use with biochemical recurrence in patients treated with radical prostatectomy for prostate cancerMalte Rieken, Luis A Kluth, Evanguelos Xylinas, et al.
Urology|October 11, 2008
Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter studyMario I Fernández, Shahrokh F Shariat, Vitaly Margulis, et al.
BJU International|May 15, 2014
The role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma following radical nephroureterectomy: a retrospective studyIlaria Lucca, Wassim Kassouf, Anil Kapoor, et al.
Urologic Oncology|September 24, 2013
Does increasing the nodal yield improve outcomes in contemporary patients without nodal metastasis undergoing radical prostatectomy?Luis A Kluth, Evanguelos Xylinas, Malte Rieken, et al.
Urology|May 25, 2016
Altered Expression of the Transcription Factor Forkhead Box A1 (FOXA1) Is Associated With Poor Prognosis in Urothelial Carcinoma of the Upper Urinary TractJay D Raman, Joshua I Warrick, Carla Caruso, et al.
European Urology|October 7, 2011
The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomyThomas F Chromecki, Eugene K Cha, Harun Fajkovic, et al.
Urologic Oncology|May 11, 2010
Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomyJeffery C Wheat, Alon Z Weizer, J Stuart Wolf, et al.
Pageof 17